Letter: Extended-Release Lorazepam as a Safe and Effective Option for Treating Catatonia in an Individual with Down Syndrome

J Child Adolesc Psychopharmacol. 2025 Sep;35(7):436-437. doi: 10.1089/cap.2025.0061. Epub 2025 May 26.

Authors

Kyung Eun Paik^{1

2}, Aaron Hauptman^{1

2}

Affiliations

¹ Department of Neuropsychiatry, Kennedy Krieger Institute, Baltimore, Maryland, USA.
² Department of Child & Adolescent Psychiatry, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

PMID: 40418179
DOI: 10.1089/cap.2025.0061

No abstract available

Publication types

Letter